SRX
Click for more information
0.00% 17.5¢ sierra rutile holdings limited

Clinical Trial Objectives, page-30

  1. oldtimer2
    1,256 Posts.
    lightbulb Created with Sketch. 86
    clock Created with Sketch.
    17/03/15
    15:51
    Post #: 14928927
    Except that the company has pointed out that the liver only cases are the most common and the ones that would otherwise be most likely to kill people off. Hopefully we will get a more articulate plain English statement of interpretation from the company soon. They clearly need some shareholder media writer onboard.
    SRX Price at posting: $17.51 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS ClearVue successfully raises $7.5 million via institutional placement
right-arrow Created with Sketch.
NEWS Canyon-1H well drilling advancing as planned, with promising results observed and key milestones on track for completion by late October
right-arrow Created with Sketch.
LGP Record revenue of $10.2 million as European demand drives 40% quarterly growth, with $1 million in operating cash inflow and $0.5 million in cost savings forecast
right-arrow Created with Sketch.
NEWS MOU executed with leading maritime partner to advance plans for a multi-user transhipping facility in West Pilbara
right-arrow Created with Sketch.
NVU Nanoveu commences crucial benchmark testing for System-on-aChip (SoC) Semiconductor technology
right-arrow Created with Sketch.
BM8 Learn of the ASX-listed company that is well-placed to respond to the future global energy demand
right-arrow Created with Sketch.
watchlist Created with Sketch. Add SRX (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.